Fosinopril (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fosinopril" in English language version.

refsWebsite

Global rank English rank

8nih.gov

4^th place

6doi.org

2^nd place

1fda.gov

447^th place

338^th place

1books.google.com

3^rd place

1semanticscholar.org

11^th place

8^th place

books.google.com

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 468. ISBN 9783527607495.

doi.org

Pilote L, Abrahamowicz M, Eisenberg M, Humphries K, Behlouli H, Tu JV (May 2008). "Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure". CMAJ. 178 (10): 1303–1311. doi:10.1503/cmaj.060068. PMC 2335176. PMID 18458262.
Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T (November 1993). "Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats". Journal of Molecular and Cellular Cardiology. 25 (11): 1369–1380. doi:10.1006/jmcc.1993.1149. PMID 8301670.
Erhardt L, MacLean A, Ilgenfritz J, Gelperin K, Blumenthal M (December 1995). "Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group". European Heart Journal. 16 (12): 1892–1899. doi:10.1093/oxfordjournals.eurheartj.a060844. PMID 8682023.
Zannad F, Chati Z, Guest M, Plat F (October 1998). "Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators". American Heart Journal. 136 (4 Pt 1): 672–680. doi:10.1016/s0002-8703(98)70015-8. PMID 9778071.
Greenbaum R, Zucchelli P, Caspi A, Nouriel H, Paz R, Sclarovsky S, et al. (January 2000). "Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency". British Journal of Clinical Pharmacology. 49 (1): 23–31. doi:10.1046/j.1365-2125.2000.00103.x. PMC 2014892. PMID 10606834.
Duchin KL, Waclawski AP, Tu JI, Manning J, Frantz M, Willard DA (January 1991). "Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects". Journal of Clinical Pharmacology. 31 (1): 58–64. doi:10.1002/j.1552-4604.1991.tb01887.x. PMID 1646240. S2CID 24683211.

fda.gov

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.

nih.gov

pubmed.ncbi.nlm.nih.gov

Pilote L, Abrahamowicz M, Eisenberg M, Humphries K, Behlouli H, Tu JV (May 2008). "Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure". CMAJ. 178 (10): 1303–1311. doi:10.1503/cmaj.060068. PMC 2335176. PMID 18458262.
Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T (November 1993). "Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats". Journal of Molecular and Cellular Cardiology. 25 (11): 1369–1380. doi:10.1006/jmcc.1993.1149. PMID 8301670.
Erhardt L, MacLean A, Ilgenfritz J, Gelperin K, Blumenthal M (December 1995). "Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group". European Heart Journal. 16 (12): 1892–1899. doi:10.1093/oxfordjournals.eurheartj.a060844. PMID 8682023.
Zannad F, Chati Z, Guest M, Plat F (October 1998). "Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators". American Heart Journal. 136 (4 Pt 1): 672–680. doi:10.1016/s0002-8703(98)70015-8. PMID 9778071.
Greenbaum R, Zucchelli P, Caspi A, Nouriel H, Paz R, Sclarovsky S, et al. (January 2000). "Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency". British Journal of Clinical Pharmacology. 49 (1): 23–31. doi:10.1046/j.1365-2125.2000.00103.x. PMC 2014892. PMID 10606834.
Duchin KL, Waclawski AP, Tu JI, Manning J, Frantz M, Willard DA (January 1991). "Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects". Journal of Clinical Pharmacology. 31 (1): 58–64. doi:10.1002/j.1552-4604.1991.tb01887.x. PMID 1646240. S2CID 24683211.

ncbi.nlm.nih.gov

Pilote L, Abrahamowicz M, Eisenberg M, Humphries K, Behlouli H, Tu JV (May 2008). "Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure". CMAJ. 178 (10): 1303–1311. doi:10.1503/cmaj.060068. PMC 2335176. PMID 18458262.
Greenbaum R, Zucchelli P, Caspi A, Nouriel H, Paz R, Sclarovsky S, et al. (January 2000). "Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency". British Journal of Clinical Pharmacology. 49 (1): 23–31. doi:10.1046/j.1365-2125.2000.00103.x. PMC 2014892. PMID 10606834.

semanticscholar.org

api.semanticscholar.org

Duchin KL, Waclawski AP, Tu JI, Manning J, Frantz M, Willard DA (January 1991). "Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects". Journal of Clinical Pharmacology. 31 (1): 58–64. doi:10.1002/j.1552-4604.1991.tb01887.x. PMID 1646240. S2CID 24683211.